IRIS
SANARICA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 712
EU - Europa 145
AS - Asia 69
OC - Oceania 1
Totale 927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 712
IT - Italia 70
CN - Cina 41
SE - Svezia 40
SG - Singapore 15
GB - Regno Unito 11
DE - Germania 8
VN - Vietnam 8
CZ - Repubblica Ceca 5
FI - Finlandia 4
FR - Francia 4
IN - India 4
NL - Olanda 3
AU - Australia 1
JP - Giappone 1
Totale 927
Salva come PNG Salva come JPEG
Città #
Fairfield 120
Chandler 99
Woodbridge 60
Houston 49
Ashburn 48
Cambridge 48
Nyköping 40
Seattle 38
Wilmington 36
Bari 21
New York 14
Ann Arbor 12
Lawrence 12
Beijing 11
Des Moines 11
Roxbury 11
Singapore 11
Inglewood 9
Dong Ket 8
Milan 7
Nanjing 6
San Diego 6
Taranto 6
Brno 5
Brooklyn 4
Helsinki 3
Jiaxing 3
London 3
Los Angeles 3
Santa Clara 3
Hebei 2
Hefei 2
Nanchang 2
Naples 2
Nulvi 2
Pune 2
Sennori 2
Seveso 2
St Helens 2
Tianjin 2
Amsterdam 1
Chicago 1
Dearborn 1
Falkenberg 1
Gioia Del Colle 1
Guangzhou 1
Hounslow 1
Jinan 1
Kagoya 1
Kilburn 1
Leawood 1
Liverpool 1
Messina 1
Monmouth Junction 1
Mumbai 1
Munich 1
Nürnberg 1
Padova 1
Princeton 1
Redwood City 1
San Francisco 1
Sassari 1
Shenyang 1
Sindelfingen 1
Sydney 1
Valenzano 1
Wuhan 1
Wuxi 1
Totale 755
Salva come PNG Salva come JPEG
Nome #
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 125
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 124
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 112
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 100
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 93
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds 81
Dual action of mexiletine and its pyrroline derivatives as skeletal muscle sodium channel blockers and anti-oxidant compounds: Toward novel therapeutic potential 68
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 58
"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic 45
Effect of exercise on telomere length and telomere proteins expression in mdx mice 40
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 39
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 37
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 36
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 14
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 12
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 11
Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine 5
Totale 1.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 0 0 5 33 22 12 17 29 22 13 12 6
2020/2021216 13 9 4 34 21 4 11 13 19 43 27 18
2021/2022107 13 0 3 0 0 10 9 0 11 10 20 31
2022/2023225 16 34 15 23 23 23 1 26 39 4 11 10
2023/2024100 5 20 3 11 8 21 2 3 2 8 5 12
2024/202541 19 4 18 0 0 0 0 0 0 0 0 0
Totale 1.000